Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI
Big Pharmas are moving beyond AI hype and starting to explain how the technology is being used in practice.
James Waldron
May 7, 2026 9:10am
Biopharma veteran takes her CEO Cue—Chutes & Ladders
May 8, 2026 8:30am
Banyan BioInnovations launches with $100M, Icon collab
May 7, 2026 2:13pm
BeOne shelves 5 cancer programs, halts ph. 2 arthritis trial
May 7, 2026 11:15am
New antibodies stop measles from stabbing cells, study finds
May 7, 2026 11:00am
Fierce Pharma
FDA to reconsider rejected cell therapy. Could uniQure be next?
May 7, 2026 10:40am
More News
Blackstone Invests $250M in Anagram to reduce CF pill burden
May 7, 2026 10:36am
Ascendis axes IL-2 program in retreat from oncology expansion
May 7, 2026 10:10am
Entrada's stock craters as DMD data underperforms expectations
May 7, 2026 9:12am
Ipsen scuttles liver disease candidates from Albireo acquisition
May 6, 2026 3:10pm
See more stories
